resveratrol has been researched along with formononetin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Dutour, R; Poirier, D | 1 |
Hao, X; Hou, Y; Jia, X; Jia, Y; Li, N; Li, W; Pan, L; Shi, M; Si, Y; Song, Y; Zheng, C; Zhou, D | 1 |
1 review(s) available for resveratrol and formononetin
Article | Year |
---|---|
Inhibitors of cytochrome P450 (CYP) 1B1.
Topics: Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Structure-Activity Relationship | 2017 |
2 other study(ies) available for resveratrol and formononetin
Article | Year |
---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Natural neuro-inflammatory inhibitors from Caragana turfanensis.
Topics: Animals; Anti-Inflammatory Agents; Caragana; Cell Line; Coumarins; Inhibitory Concentration 50; Lipopolysaccharides; Magnetic Resonance Spectroscopy; Microglia; Molecular Conformation; Nitric Oxide; Plant Extracts | 2017 |